Publications by authors named "P Dockery"

Claim this Profile
P
Primary suspect drugs of cataracts in pediatric patients: FDA adverse events reporting database analysis.
Ayesh Ali, Philip W Dockery, David G Downes, Deborah K VanderVeen, Abdelrahman M Elhusseiny

J Cataract Refract Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive ER stress promotes mitochondrial remodelling and longevity through PERK-dependent MERCS assembly.
Jose C Casas-Martinez, Qin Xia, Penglin Li, Maria Borja-Gonzalez, Antonio Miranda-Vizuete, Peter Dockery

Cell Death Differ· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Impact of Reperfusion in the Development of a Safe Compression Therapy.
Rachel Beatty, Pascal Paco Farina, Joanne O'Dwyer, Peter Dockery, Alanna Stanley

Microsc Microanal· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peroxiredoxin 2 regulates DAF-16/FOXO mediated mitochondrial remodelling in response to exercise that is disrupted in ageing.
Qin Xia, Penglin Li, José C Casas-Martinez, Antonio Miranda-Vizuete, Emma McDermott, Peter Dockery

Mol Metab· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of Sclerouveitis to Endogenous Endophthalmitis.
Sairi Zhang, J Anthony Chacko, Riley N Sanders, Eric R Rosenbaum, Philip W Dockery

Case Rep Ophthalmol Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis